top of page
White Papers

​

The dangers of blue light: what is it and how can we protect against its threat?

 

A growing body of medical research is beginning to focus on the role played by harmful blue light in damaging the eye, leading to conditions like age-related macular degeneration (AMD).

​

This has been prompted by two global factors: an ageing population and a younger generation making regular, heavy use of blue light-emitting technology.

​

In this whitepaper we examine the effects of blue light, the eye’s natural resistance to it, and how that resistance can be bolstered.

Whitepaper-cover-blue
Case-for-early-screening
Age-related macular degeneration:
the case for early screening
​

Our whitepaper explores the development of AMD and helps you to understand the key risk factors. Our analysis spans non-modifiable risk factors such as family history and genetic, as well as modifiable factors like smoking, diet and BMI.

​

Read our paper for insights into:

  • The academic case for targeted screening

  • Lifestyle factors affecting AMD development

  • Understanding wet and dry AMD

  • How ophthalmologists can raise awareness of AMD

The use of MPS II as part of a macular screening programme
​

Prevention is better than intervention

​

This whitepaper outlines pragmatic guidelines for a coherent strategy around the prevention and management of age-related macular degeneration (AMD).

  • Written by Dr. Scott Mackie, a Consultant Ophthalmologist.

Macular-screening-programme
bottom of page